Salvador Francisco Aliño Pellicer

Emeritus Professor

University of Valencia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Salvador Francisco Aliño Pellicer is an Emeritus Professor at the University of Valencia, Spain. His research areas include gene transfer techniques in transplantation, personalized medicine in pediatric oncology, and pharmacogenetics related to liver transplant outcomes. He has authored several articles exploring the effects of pharmacogene variants on clinical therapy and advancements in the use of antisense oligonucleotides for therapeutic applications.

Articles (7)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Maria Jose Herrero

University of Valencia

SPAIN

View details

David Hervas

Profesor Ayudante Doctor

Universitat Politècnica de València

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Salvador Francisco Aliño Pellicer

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation

Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy

Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells

Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up

Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against <i>Sporothrix schenckii</i>

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement

CYP3A53 and CYP2C83 variants influence exposure and clinical outcomes of tacrolimus-based therapy.

Collaborators (2)

Maria Jose Herrero

David Hervas

Make your next move.

Salvador Francisco Aliño Pellicer

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation

Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy

Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells

Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up

Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against <i>Sporothrix schenckii</i>

Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement

CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.

Collaborators (2)

Maria Jose Herrero

David Hervas

Make your next move.

CYP3A53 and CYP2C83 variants influence exposure and clinical outcomes of tacrolimus-based therapy.